2 No-Brainer Biotech Stocks to Buy Right Now
Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...
Fierce Biotech1d
Nanobiotix tweaks J&J licensing deal for phase 3 cancer drug to eke out cash
J&J will now pick up almost the full tab for the phase 3 trial, and, in return, Nanobiotix will see the potential milestone ...
Fierce Biotech1d
Vincerx, left in limbo by collapsed deal, moves to merge with AI company to escape cash crisis
Vincerx Pharma has found a fast fix for the uncertainty over its future. | Vincerx Pharma has found a fast fix for the ...
JD Supra7h
FDA Funding Changes Could Impact Biotech M&A
With companies constantly developing new therapies and technologies, the biotech industry is a hotbed of innovation. This dynamic environment ...
Purple Biotech sees cash runway into mid-2026
Purple Biotech (PPBT) had cash and cash equivalents and short-term deposits of $8.2 million, providing the Company a ...
Legend Biotech sees cash runway into 2Q26
Cash and cash equivalents, and time deposits of $1.1 billion, as of December 31, 2024, which Legend Biotech (LEGN) believes will provide ...
Is Insmed Incorporated (INSM) a Best Biotech Stock According to Billionaires?
We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against other ...